Interactome is advancing its novel biologic platform, a next-generation, multi-targeted Secretome containing hundreds of biologically active proteins and other factors crucial for cellular regeneration, the modulation of inflammation, cell recovery and turnover. We believe this novel platform holds significant clinical potential across a range of important underserved conditions in neurology, oncology, and cardiology.